Reference : Cost-effectiveness of abaloparatide for the treatment of postmenopausal women with os...
Scientific congresses and symposiums : Paper published in a journal
Human health sciences : General & internal medicine
http://hdl.handle.net/2268/223169
Cost-effectiveness of abaloparatide for the treatment of postmenopausal women with osteoporosis.
English
Hiligsmann, M. []
Williams, S.A. []
Fitzpatrick, L.A. []
Reginster, Jean-Yves mailto [Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
Apr-2018
Osteoporosis International
Springer
29 S1
43-44
Yes (verified by ORBi)
No
International
0937-941X
1433-2965
Germany
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
du 19 au 22 avril 2018
WCO-IOF-ESCEO
Cracovie
Pologne
http://hdl.handle.net/2268/223169

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Cost-effectiveness of abaloparatide for the treatment of postmenopausal women with osteoporosis..pdfPublisher postprint1.06 MBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.